Found 11 matching trials
A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. PHASE3 This was a randomized, double-blind, parallel, multicenter, multinational s...
Show More Location
AES - DRS - Medical Center Synexus Sofia EOOD
Learn More & Join Trial
A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects PHASE1 This study is a Pilot Phase 1, Double-Blind, Randomized, Two-arm, Parallel ...
Show More Learn More & Join Trial
Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects PHASE1 This study is to compare PK, PD, safety, tolerability, and immunogenicity p...
Show More Learn More & Join Trial
A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva PHASE1 Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Show More Location
Biokinetica - Early Phase Institute
Learn More & Join Trial
Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects PHASE1 Part I of the study: This is a randomised, single-dose, subcutaneous inject...
Show More Location
Huashan Hospital,Fudan University
Learn More & Join Trial
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. PHASE2 Aortic stenosis is a condition whereby one of the heart valves (aortic valv...
Show More Location
Clinical Research Facility University of Edinburgh
Learn More & Join Trial
Comparative Efficacy, Safety, PK, and Immunogenicity Study PHASE3 this comparative clinical study is designed to demonstrate that LY06006 and...
Show More Location
Clinical Trials Management Services, LLC
Learn More & Join Trial
A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection PHASE1 This trial is a randomized, double-blind, three-arm, parallel-group, pharma...
Show More Location
Parexel International GmbH, Early Phase Clinical Unit Berlin
Learn More & Join Trial
Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis PHASE3 This study was conducted to assess if there were any clinically meaningful ...
Show More Location
Sandoz Investigational Site
Learn More & Join Trial
Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® PHASE1 A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-...
Show More Location
Xentria Investigative Site
Learn More & Join Trial